ES539275A0 - Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo - Google Patents

Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo

Info

Publication number
ES539275A0
ES539275A0 ES539275A ES539275A ES539275A0 ES 539275 A0 ES539275 A0 ES 539275A0 ES 539275 A ES539275 A ES 539275A ES 539275 A ES539275 A ES 539275A ES 539275 A0 ES539275 A0 ES 539275A0
Authority
ES
Spain
Prior art keywords
bifanazole
derivatives
procedure
obtaining
active product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539275A
Other languages
English (en)
Other versions
ES8601691A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8601691A1 publication Critical patent/ES8601691A1/es
Publication of ES539275A0 publication Critical patent/ES539275A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES539275A 1983-03-30 1984-12-31 Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo Granted ES539275A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311700 DE3311700A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray

Publications (2)

Publication Number Publication Date
ES8601691A1 ES8601691A1 (es) 1985-11-16
ES539275A0 true ES539275A0 (es) 1985-11-16

Family

ID=6195161

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530845A Expired ES8503946A1 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539275A Granted ES539275A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo
ES539274A Granted ES539274A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES530845A Expired ES8503946A1 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES539274A Granted ES539274A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo

Country Status (18)

Country Link
JP (1) JPS59184125A (es)
KR (1) KR840008283A (es)
AU (1) AU564979B2 (es)
BE (1) BE899277A (es)
CA (1) CA1212328A (es)
CH (1) CH660304A5 (es)
DE (1) DE3311700A1 (es)
ES (3) ES8503946A1 (es)
FR (1) FR2543436B1 (es)
GB (1) GB2137090B (es)
GR (1) GR81880B (es)
IL (1) IL71363A0 (es)
IT (1) IT1173762B (es)
LU (1) LU85272A1 (es)
PH (1) PH20964A (es)
PT (1) PT78312B (es)
SE (1) SE8401747L (es)
ZA (1) ZA842336B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2555555B2 (ja) * 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
US5246716A (en) * 1992-01-10 1993-09-21 W. Neudorff Gmbh Kg Fatty acid-based antifungal composition having residual activity
DK0870497T3 (da) * 1995-12-14 2004-05-24 Taisho Pharmaceutical Co Ltd Aerosolpræparat
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
JPS6018655B2 (ja) * 1976-01-01 1985-05-11 バイエル・アクチエンゲゼルシヤフト アゾリル−(1)−メタン類及びそれらの塩
JPS5598112A (en) * 1979-01-17 1980-07-25 Sumitomo Chem Co Ltd Liquid medicine for external use
DE3019027A1 (de) * 1980-05-19 1981-11-26 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
DE3311700A1 (de) 1984-10-04
ES530845A0 (es) 1985-04-16
ES8601691A1 (es) 1985-11-16
FR2543436A1 (fr) 1984-10-05
CH660304A5 (de) 1987-04-15
ES8601690A1 (es) 1985-11-16
ES8503946A1 (es) 1985-04-16
KR840008283A (ko) 1984-12-14
FR2543436B1 (fr) 1988-12-16
ES539274A0 (es) 1985-11-16
CA1212328A (en) 1986-10-07
BE899277A (fr) 1984-10-01
GR81880B (es) 1984-12-12
GB8408066D0 (en) 1984-05-10
IT1173762B (it) 1987-06-24
GB2137090A (en) 1984-10-03
AU564979B2 (en) 1987-09-03
SE8401747L (sv) 1984-10-01
JPS59184125A (ja) 1984-10-19
LU85272A1 (de) 1984-11-14
PT78312B (en) 1986-06-02
AU2623584A (en) 1984-10-04
PT78312A (en) 1984-04-01
SE8401747D0 (sv) 1984-03-29
GB2137090B (en) 1986-07-09
IL71363A0 (en) 1984-06-29
IT8420304A0 (it) 1984-03-29
ZA842336B (en) 1984-11-28
PH20964A (en) 1987-06-10

Similar Documents

Publication Publication Date Title
ES533097A0 (es) Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
ES511498A0 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol
ES527986A0 (es) Procedimiento para la produccion de derivados de 1-azolil-2-aril-3-fluoro-alcan-2-ol.
MX6717E (es) Procedimiento para la preparacion de bis-esteres 6'acilaminopenicilanoiloximetilicos del acido 1,1-dioxido penicilanico
ES518968A0 (es) Un procedimiento para la preparacion de derivados del acido ascorbico.
AR240791A1 (es) Procedimiento para la produccion de etileno y propileno.
ES521337A0 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES492666A0 (es) Un procedimiento para la preparacion de derivados del 2,3- dihidro-5- acilbenzofuranos 2,6,7- trisustituidos.
ES544290A0 (es) Un procedimiento para la preparacion de derivados del indano
ES527985A0 (es) Procedimiento para la produccion de derivados de 1-fluoro-1-ariloxi-3-azolilmetil-2-alcanol.
ES534924A0 (es) Procedimiento para la obtencion de monoeteres alifaticos del 2,2-dimetilpropan-1,3-diol
ES494546A0 (es) Un procedimiento para la preparacion de derivados del pirrol
ES489186A0 (es) Un procedimiento para la preparacion de derivados del acido penicilamico 6-b-sustituidos.
ES493839A0 (es) Procedimiento para la obtencion de esteres del acido n-me- til-o-pirazol (4)il-carbamico,de efecto pesticida
ES539275A0 (es) Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo
ES523664A0 (es) Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico.
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
ES493068A0 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
ES539290A0 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
ES549384A0 (es) Procedimiento para la obtencion de derivados del 2-aminome- til-2-penem.
ES518912A0 (es) Un procedimiento para la preparacion de derivados del acido penicilanico.
MX159452A (es) Procedimiento para la preparacion del 8-metoxi-4,8-dimetil-1-(4-isopropilfenil)-no-nano
ES494298A0 (es) Procedimiento para la preparacion de derivados azoicos.
ES496355A0 (es) Un procedimiento para la produccion de un producto absorbente no desintegrable flexible.
ES528109A0 (es) Procedimiento para la obtencion del 2,4,6 triyodofenol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050723